首页> 外国专利> Method and the kit which decide the patient where the danger of dying between the blood poisoning characteristic shock is high quickly

Method and the kit which decide the patient where the danger of dying between the blood poisoning characteristic shock is high quickly

机译:决定患者血液中毒特征性休克之间死亡的危险性高的方法和试剂盒

摘要

This invention regards the field of remedy of critical medical syndrome like the critical blood poisoning and the blood poisoning characteristic shock. Especially, this invention early appraises the danger of the death concerning the patient of the blood poisoning characteristic shock which for example accompanies one further internal organs incompletion, concerning the patient of the critical blood poisoning which accompanies two internal organs incompletion, offers method and the kit which assist the decision in regard to remedy. Method of this invention one which is selected or is based on the analysis of revelation profile of some genes from the group which consists of HLA-DRB4, FOSB, GPR109B, RBP7, TLR7, IL15, HLA-C, AMFR, LOC96610, IRF5, MGC29506, EDG3, IGLV1-44, IFIT2, IFI44, EPSTI1, TNFRSF17, AREG, THBS1, CTLS1, TFPI, PHACTR2, PFKFB2 and CHIT1. Selective figure It is not
机译:本发明涉及危重血液中毒和血液中毒特征性休克等危重医学综合症的治疗领域。尤其是,本发明及早评估例如伴随另一内部器官功能不全的血液中毒特征性休克患者的死亡危险,关于伴随两个内部器官功能不全的严重血液中毒患者的死亡危险,提供方法和试剂盒这有助于有关补救措施的决定。本发明的方法是选自或基于以下基因的揭示谱分析的一种方法:HLA-DRB4,FOSB,GPR109B,RBP7,TLR7,IL15,HLA-C,AMFR,LOC96610,IRF5, MGC29506,EDG3,IGLV1-44,IFIT2,IFI44,EPSTI1,TNFRSF17,AREG,THB​​S1,CTLS1,TFPI,PHACTR2,PFKFB2和CHIT1。<选择图>不是

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号